Clinical Trial Update: Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet [Phase 3]

View source ↗

Summary

Phase 3 trial comparing tolterodine extended-release capsule to immediate-release tablet for urinary incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Incontinence

Drugs mentioned

• Tolterodine Extended Release Capsule (tolterodine)
• Tolterodine Immediate Release Tablet (tolterodine)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Urinary Incontinence | Phase 3 | Status: COMPLETED